Clinical Trial Update: Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating EPA-enriched enteral nutrition in patients undergoing upper gastrointestinal cancer surgery for esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• EPA-enriched enteral nutrition (eicosapentaenoic acid)

Snippet

Sponsor: University of Dublin, Trinity College | Conditions: Esophageal Cancer | Phase 4 | Status: UNKNOWN